Brief: Akoya Reports Third Quarter Results, Raises Full Year 2022 Revenue Guidance
Nov 7 (Reuters) - Akoya Biosciences Inc AKYA.O :
* AKOYA REPORTS RECORD REVENUE WITH 40% YOY GROWTH IN THE
THIRD
QUARTER AND RAISES FULL YEAR 2022 REVENUE GUIDANCE
* Q3 REVENUE ROSE 40 PERCENT TO $18.9 MILLION
* RAISING ITS FULL YEAR 2022 REVENUE GUIDANCE RANGE TO $73
MILLION
-$75 MILLION
* QTRLY NET LOSS PER SHARE $0.47
* Q3 EARNINGS PER SHARE VIEW $-0.44, REVENUE VIEW $17.7
MILLION --
REFINITIV IBES DATA
* FY2022 REVENUE VIEW $72.3 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9MJdrk
Further company coverage: AKYA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks